Home » Topics » BioWorld Science

BioWorld Science
RSS

AZD-9574: a selective PARP1 inhibitor suitable for cancer treatment

April 4, 2022

Novel TLR4 murine model to study dermal sensitization by nickel salts

April 4, 2022

Sosei Heptares presents novel GLP-1 receptor antagonist HTL-0033097

April 1, 2022

Humanized mouse model to asses acute toxicity of immune drug treatments

April 1, 2022

New orthotopic xenograft breast cancer murine models developed

April 1, 2022

Novel humanized HIS-BRGS mouse model to evaluate immune-related kidney toxicities

April 1, 2022

Telomere to telomere, the human genome is done

April 1, 2022

RemeGen discloses new anti-c-Met antibody-drug conjugates

April 1, 2022

CNRS and collaborators patent acetylcholinesterase reactivators

April 1, 2022

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...